Key statistics
On Tuesday, Vir Biotechnology Inc (VIR:NSQ) closed at 7.51, -25.57% below its 52-week high of 10.09, set on Feb 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 7.25 |
|---|---|
| High | 7.67 |
| Low | 7.16 |
| Bid | 7.55 |
| Offer | 7.65 |
| Previous close | 7.28 |
| Average volume | 1.54m |
|---|---|
| Shares outstanding | 139.13m |
| Free float | 124.67m |
| P/E (TTM) | -- |
| Market cap | 1.01bn USD |
| EPS (TTM) | -3.62 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Press releases
- Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
- Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
- Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Zealand, Including Global Cost Sharing Agreement for Ongoing ECLIPSE Clinical Development Program
- Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference
More ▼
